Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2024 Nov 20:2024:9989080.
doi: 10.1155/2024/9989080. eCollection 2024.

Nurse-Led Telephone Program for Nonadherent to Treatment Type 2 Diabetics With Comorbid Depression: A Cost-Consequence and Budget Impact Analysis

Manuel Gómez-Barrera  1   2 , María Luisa Lozano-Del Hoyo  3   4 , Juan Francisco Roy  1   5 , María Teresa Fernández-Rodrigo  3   6 , Piedad Gómez-Torres  3   7 , Isabel Blázquez-Ornat  3 , Sofía Pérez-Calahorra  3 , Maria Esther Samaniego Diaz de Corcuera  8   9 , Emilia Ferrer-López  3   10 , Enrique Ramón-Arbués  1   8
Affiliations
Randomized Controlled Trial

Nurse-Led Telephone Program for Nonadherent to Treatment Type 2 Diabetics With Comorbid Depression: A Cost-Consequence and Budget Impact Analysis

Manuel Gómez-Barrera et al. J Nurs Manag. .

Abstract

Objective: To estimate the efficiency of a nurse-led telephone program for nonadherent to treatment Type 2 diabetics with comorbid depression (TELE-DD program). Design: Secondary analysis of cost-consequence and budget impact, utilizing data from a randomized clinical trial conducted in the primary healthcare setting. The target population consisted of Type 2 diabetic patients with comorbid depression who were nonadherent to their pharmacological treatment. Method: The average cost per controlled patient (glycated hemoglobin < 7%) and the incremental cost-effectiveness ratio were calculated. Similarly, the budgetary impact over 1 year of implementing this program in the region of reference of the randomized clinical trial was assessed. Results: The number of controlled patients is higher in the TELE-DD group at 6, 12, and 18 months. The average cost per controlled patient was higher in the TELE-DD group than in the control group at 6 months (€160.31 vs. €49.79), but lower at 12 (€150.09 vs. €179.59) and 18 months (€209.22 vs. €376.88). The incremental cost-effectiveness ratio at 6, 12, and 18 months was €254.47, €143.65, and €177.46, respectively. The budget impact analysis revealed that implementing the TELE-DD program would result in a reduction of €721,940.68 in expenditure for the funder in the first year of application. Conclusions: A nurse-led telephone program for nonadherent Type 2 diabetics with comorbid depression is an efficient option in the management of healthcare resources. These results highlight the role of nursing in chronic patient management and the efficient use of healthcare resources. Trial Registration: ClinicalTrials.gov Identifier: NCT04097483.

Keywords: Type 2 diabetes mellitus; budget impact; cost-consequence; depression; tele-nursing; treatment adherence.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Mean cost per controlled T2DM patient (CI 95%) at 6, 12, and 18 months (€).
Figure 2
Figure 2
ICER in 6, 12, and 18 months in cost-effectiveness plane.
See this image and copyright information in PMC

References

    1. Khan M. A. B., Hashim M. J., King J. K., Govender R. D., Mustafa H., Kaabi J. Al. Epidemiology of Type 2 Diabetes—Global Burden of Disease and Forecasted Trends. Journal of Epidemiology and Global Health . 2020;10(1) doi: 10.2991/JEGH.K.191028.001. - DOI - PMC - PubMed
    1. Butt M. D., Ong S. C., Wahab M. U., et al. Cost of Illness Analysis of Type 2 Diabetes Mellitus: The Findings From a Lower-Middle Income Country. International Journal of Environmental Research and Public Health . 2022;19(19):p. 12611. doi: 10.3390/ijerph191912611. - DOI - PMC - PubMed
    1. Ganasegeran K., Hor C. P., Jamil M. F. A., et al. A Systematic Review of the Economic Burden of Type 2 Diabetes in Malaysia. International Journal of Environmental Research and Public Health . 2020;17(16):p. 5723. doi: 10.3390/ijerph17165723. - DOI - PMC - PubMed
    1. Sun H., Saeedi P., Karuranga S., et al. IDF Diabetes Atlas: Global, Regional and Country-Level Diabetes Prevalence Estimates for 2021 and Projections for 2045. Diabetes Research and Clinical Practice . 2022;183 doi: 10.1016/j.diabres.2021.109119. - DOI - PMC - PubMed
    1. ElSayed N. A., Aleppo G., Aroda V. R., et al. 5. Facilitating Positive Health Behaviors and Well-Being to Improve Health Outcomes: Standards of Care in Diabetes—2023. Diabetes Care . 2023;46(Supplement_1):S68–S96. doi: 10.2337/dc23-S005. - DOI - PMC - PubMed

Publication types

Associated data